DE60327007D1 - Verfahren für Herz-Kreislauf-Erkrankungen - Google Patents
Verfahren für Herz-Kreislauf-ErkrankungenInfo
- Publication number
- DE60327007D1 DE60327007D1 DE60327007T DE60327007T DE60327007D1 DE 60327007 D1 DE60327007 D1 DE 60327007D1 DE 60327007 T DE60327007 T DE 60327007T DE 60327007 T DE60327007 T DE 60327007T DE 60327007 D1 DE60327007 D1 DE 60327007D1
- Authority
- DE
- Germany
- Prior art keywords
- calprotectin
- antibody
- procedure
- cardiovascular diseases
- body fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 abstract 5
- 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 abstract 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 2
- 239000010839 body fluid Substances 0.000 abstract 2
- 239000002105 nanoparticle Substances 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004879 turbidimetry Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Gyroscopes (AREA)
- Optical Head (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0229747.1A GB0229747D0 (en) | 2002-12-20 | 2002-12-20 | Assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60327007D1 true DE60327007D1 (de) | 2009-05-14 |
Family
ID=9950111
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60327007T Expired - Lifetime DE60327007D1 (de) | 2002-12-20 | 2003-12-22 | Verfahren für Herz-Kreislauf-Erkrankungen |
| DE60317931T Expired - Lifetime DE60317931T2 (de) | 2002-12-20 | 2003-12-22 | Cvd-assay |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60317931T Expired - Lifetime DE60317931T2 (de) | 2002-12-20 | 2003-12-22 | Cvd-assay |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US10101325B2 (de) |
| EP (2) | EP1573335B1 (de) |
| JP (2) | JP4653492B2 (de) |
| CN (3) | CN1729398B (de) |
| AT (2) | ATE380345T1 (de) |
| AU (1) | AU2003295142A1 (de) |
| CA (2) | CA2729365C (de) |
| DE (2) | DE60327007D1 (de) |
| DK (2) | DK1739430T3 (de) |
| ES (2) | ES2297250T3 (de) |
| GB (1) | GB0229747D0 (de) |
| NO (1) | NO20052161L (de) |
| PL (2) | PL394295A1 (de) |
| PT (1) | PT1573335E (de) |
| SI (1) | SI1573335T1 (de) |
| WO (1) | WO2004057341A2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0229747D0 (en) * | 2002-12-20 | 2003-01-29 | Axis Shield Asa | Assay |
| US7659087B2 (en) | 2004-07-23 | 2010-02-09 | Aspenbio Pharma, Inc. | Methods and devices for diagnosis of appendicitis |
| AU2005266921B2 (en) | 2004-07-23 | 2009-07-23 | Aspenbio Pharma, Inc. | Methods and devices for diagnosis of appendicitis |
| EP1862805A1 (de) * | 2006-06-01 | 2007-12-05 | University of Zürich | Verwendung von MRP 8/14-Konzentrationen zur Unterscheidung von Personen mit akutem Koronarsyndromrisiko |
| AU2010221418B2 (en) * | 2009-03-02 | 2015-06-04 | Dignity Health | Diagnostic devices and methods of use |
| WO2010128033A2 (en) * | 2009-05-07 | 2010-11-11 | Novozymes A/S | Method for purification of target polypeptides |
| US9574977B2 (en) * | 2013-02-26 | 2017-02-21 | Innova Prep | Liquid to liquid biological particle concentrator with disposable fluid path |
| EP2511704A1 (de) | 2011-04-13 | 2012-10-17 | Immundiagnostik AG | Testverfahren für intrinsisch akute Nierenverletzung |
| NO20110895A1 (no) * | 2011-06-21 | 2012-12-24 | Magne Fagerhol | Kompetitive S100A9 immunoanalyser |
| ES2402457B2 (es) * | 2011-10-19 | 2014-01-20 | Universidade De Vigo | Procedimiento para el diagnóstico de derrame pleural maligno mediante la determinación de la concentración de calprotectina en líquido pleural. |
| US9439334B2 (en) | 2012-04-03 | 2016-09-06 | X-Card Holdings, Llc | Information carrying card comprising crosslinked polymer composition, and method of making the same |
| US9122968B2 (en) | 2012-04-03 | 2015-09-01 | X-Card Holdings, Llc | Information carrying card comprising a cross-linked polymer composition, and method of making the same |
| CA2884637A1 (en) * | 2012-09-12 | 2014-03-20 | Berg Llc | Use of markers in the identification of cardiotoxic agents |
| WO2014149926A1 (en) | 2013-03-15 | 2014-09-25 | X-Card Holdings, Llc | Methods of making a core layer for an information carrying card, and resulting products |
| KR102457657B1 (ko) * | 2017-02-07 | 2022-10-21 | 리프스톤 비.브이. | 무균성 해리로 인한 임플란트 관련 임플란트 교정 위험을 진단하기 위한 바이오마커 |
| EP3385712A1 (de) | 2017-04-03 | 2018-10-10 | Gentian AS | Verbessertes calprotectin-assay |
| BR112019023210A2 (pt) * | 2017-05-09 | 2020-05-26 | Immundiagnostik Ag | Método para determinação de membros da família s100 de proteínas de ligação ao cálcio por meio de imunoturbidimetria |
| CN108196066A (zh) * | 2018-01-22 | 2018-06-22 | 安徽伊普诺康生物技术股份有限公司 | 一种测定钙防卫蛋白的试剂盒及其制备使用方法 |
| WO2019173455A1 (en) | 2018-03-07 | 2019-09-12 | X-Card Holdings, Llc | Metal card |
| WO2021229016A1 (en) * | 2020-05-13 | 2021-11-18 | Nordic Bioscience A/S | Calprotectin assay |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4287202A (en) * | 1978-05-26 | 1981-09-01 | Horrobin David F | Treatment and/or prophylaxis of spasms of coronary arteries |
| JPS55162059A (en) * | 1979-06-05 | 1980-12-17 | Mochida Pharmaceut Co Ltd | Measuring method for antigen, antibody or their complex and measurement reagent kit |
| US4401765A (en) * | 1981-09-01 | 1983-08-30 | E. I. Du Pont De Nemours And Company | Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays |
| US4480042A (en) * | 1981-10-28 | 1984-10-30 | E. I. Du Pont De Nemours And Company | Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays |
| GB8318754D0 (en) * | 1983-07-11 | 1983-08-10 | Fagerhol M K F | Human proteins anti-sera test kits |
| JPS60139621A (ja) | 1983-12-27 | 1985-07-24 | Grelan Pharmaceut Co Ltd | 抗血栓剤 |
| JPS625970A (ja) | 1985-03-15 | 1987-01-12 | Terumo Corp | ピラジン誘導体およびこれを含有する血小板凝集抑制剤 |
| EP0310361A3 (de) * | 1987-09-30 | 1989-05-24 | Beckman Instruments, Inc. | Aus drei Verzahnungen bestehendes Konjugat und Verfahren zu seiner Verwendung |
| GB2218100A (en) * | 1988-03-02 | 1989-11-08 | Erling Sundrehagen | Conjugates for the detection and/or quantification of antigenic substances in body fluids |
| CA2023803C (en) * | 1989-08-23 | 1999-05-18 | Takeshi Miyazaki | Method for measuring an immunologically active material and apparatus suitable for practicing said method |
| US5455160A (en) * | 1993-05-27 | 1995-10-03 | Fagerhol; Magne K. | Diagnostic test and kit for disease or disorders in the digestive system |
| US5776348A (en) * | 1995-02-07 | 1998-07-07 | Massachusetts Institute Of Technology | Mineral precipitation system and method for inhibiting mineral precipitate formation |
| DK0937259T3 (da) * | 1996-11-01 | 2005-01-31 | Magne K Fagerhol | Fremgangsmåde til ekstraktion af proteiner |
| PT1003501E (pt) * | 1997-04-02 | 2005-07-29 | Brigham & Womens Hospital | Utilizacao de um agente para reduzir o risco de doencas cardiovasculares |
| GB9816088D0 (en) * | 1998-07-23 | 1998-09-23 | Axis Biochemicals Asa | System |
| JP2002523749A (ja) * | 1998-08-20 | 2002-07-30 | アクシス シールド エイエスエイ | 心血管疾患のためのアッセイ方法 |
| WO2001002853A2 (en) * | 1999-07-05 | 2001-01-11 | K.U. Leuven Research & Development | DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY |
| WO2001015744A1 (en) | 1999-08-31 | 2001-03-08 | The Brigham And Women's Hospital, Inc. | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| FR2800636A1 (fr) * | 1999-11-05 | 2001-05-11 | Bio Merieux | Particules composites, conjugues derives, leur procede de preparation et utilisations |
| US7011952B2 (en) * | 2000-02-22 | 2006-03-14 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
| US20030059461A1 (en) * | 2000-06-06 | 2003-03-27 | Sibtech, Inc. | Molecular delivery vehicle for delivery of selected compounds to targets |
| AU2001280210A1 (en) * | 2000-08-29 | 2002-03-13 | Kyowa Medex Co., Ltd. | Highly reproducible agglutination immunoassay method and reagents |
| JP2002318233A (ja) * | 2001-04-19 | 2002-10-31 | Shino Test Corp | 測定対象物質の比濁法測定試薬及び測定対象物質の比濁法測定方法 |
| AU2002305394A1 (en) * | 2001-05-04 | 2002-11-18 | Biosite, Inc. | Diagnostic markers of acute coronary syndromes and methods of use thereof |
| GB0229747D0 (en) * | 2002-12-20 | 2003-01-29 | Axis Shield Asa | Assay |
| FR2872579B1 (fr) * | 2004-06-30 | 2006-11-24 | Pasteur Institut | Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha |
| WO2007106781A2 (en) * | 2006-03-10 | 2007-09-20 | University Of Rochester | Ecg-based differentiation of lqt1 and lqt2 mutation |
-
2002
- 2002-12-20 GB GBGB0229747.1A patent/GB0229747D0/en not_active Ceased
-
2003
- 2003-12-22 CA CA2729365A patent/CA2729365C/en not_active Expired - Lifetime
- 2003-12-22 DK DK06021890T patent/DK1739430T3/da active
- 2003-12-22 PL PL394295A patent/PL394295A1/pl not_active IP Right Cessation
- 2003-12-22 PL PL377476A patent/PL216385B1/pl not_active IP Right Cessation
- 2003-12-22 CN CN2003801069127A patent/CN1729398B/zh not_active Expired - Fee Related
- 2003-12-22 US US10/539,797 patent/US10101325B2/en active Active
- 2003-12-22 DK DK03786143T patent/DK1573335T3/da active
- 2003-12-22 EP EP03786143A patent/EP1573335B1/de not_active Expired - Lifetime
- 2003-12-22 AT AT03786143T patent/ATE380345T1/de active
- 2003-12-22 ES ES03786143T patent/ES2297250T3/es not_active Expired - Lifetime
- 2003-12-22 CN CN2012100207169A patent/CN102608326A/zh active Pending
- 2003-12-22 DE DE60327007T patent/DE60327007D1/de not_active Expired - Lifetime
- 2003-12-22 CN CN201010167371.0A patent/CN101893635B/zh not_active Expired - Fee Related
- 2003-12-22 WO PCT/GB2003/005607 patent/WO2004057341A2/en active IP Right Grant
- 2003-12-22 ES ES06021890T patent/ES2323475T3/es not_active Expired - Lifetime
- 2003-12-22 AT AT06021890T patent/ATE427498T1/de active
- 2003-12-22 DE DE60317931T patent/DE60317931T2/de not_active Expired - Lifetime
- 2003-12-22 SI SI200331123T patent/SI1573335T1/sl unknown
- 2003-12-22 CA CA002504876A patent/CA2504876A1/en not_active Abandoned
- 2003-12-22 PT PT03786143T patent/PT1573335E/pt unknown
- 2003-12-22 JP JP2004561672A patent/JP4653492B2/ja not_active Expired - Fee Related
- 2003-12-22 AU AU2003295142A patent/AU2003295142A1/en not_active Abandoned
- 2003-12-22 EP EP06021890A patent/EP1739430B1/de not_active Expired - Lifetime
-
2005
- 2005-05-03 NO NO20052161A patent/NO20052161L/no not_active Application Discontinuation
-
2009
- 2009-09-24 JP JP2009219158A patent/JP5744385B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-28 US US13/170,387 patent/US20110318847A1/en not_active Abandoned
-
2018
- 2018-10-15 US US16/159,786 patent/US20190049439A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052161L (no) | Analysemetode for hjerte-karsykdom | |
| Sener et al. | Rapid real-time detection of procalcitonin using a microcontact imprinted surface plasmon resonance biosensor | |
| Ertürk et al. | Microcontact imprinting based surface plasmon resonance (SPR) biosensor for real-time and ultrasensitive detection of prostate specific antigen (PSA) from clinical samples | |
| NO20076656L (no) | Forbedrede immunoassay metoder | |
| WO2007011936A3 (en) | Lateral flow assay and device using magnetic particles | |
| WO2010038974A3 (ko) | 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트 | |
| ATE538386T1 (de) | Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen | |
| ATE438853T1 (de) | Diagnostische testvorrichtung | |
| RU2011125320A (ru) | Способы, устройства и наборы для детекции или мониторинга острого повреждения почек | |
| JP2012509477A5 (de) | ||
| EP2538218A8 (de) | Biochemische Marker zur Bewertung des CVD-Risikos | |
| ATE411525T1 (de) | Nachweis einer histonmodifikation in zellfreien nukleosomen | |
| ATE410687T1 (de) | Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test | |
| WO2007061793A3 (en) | Modified cardiolipin and uses therefor | |
| DE602006021777D1 (de) | Diagnoseverfahren für präeklampsie | |
| Kurihara et al. | Fabrication of carboxylated silicon nitride sensor chips for detection of antigen–antibody reaction using microfluidic reflectometric interference spectroscopy | |
| Singh et al. | Elevated serum SIRT 2 may differentiate parkinson’s disease from atypical parkinsonian syndromes | |
| Pasinszki et al. | Advances in celiac disease testing | |
| DE60130919D1 (de) | Durchflussvorrichtung, diagnostischer kit diese enthaltend und gebrauch für den nachweis von analyten in einer probe | |
| CN103472237A (zh) | 一种生物敏感芯片及其制备方法和用途 | |
| WO2008063663A3 (en) | Poly (ethylene glycol) anti-body detection assays and kits for performing thereof | |
| WO2008067008A3 (en) | A method for the quantitative evaluation of sex hormones in a serum sample | |
| ATE412181T1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
| WO2008067007A3 (en) | A method for quantitative measurement of thyroid homrones and related antibodies in a serum sample | |
| DE602004019134D1 (de) | Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803 |
|
| R082 | Change of representative |
Ref document number: 1739430 Country of ref document: EP Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803 |